Trial intelligence / Profile preview

Effectiveness of cephalexin on facial wound healing

IRCT20260513069382N1Phase 3Recruiting

Sponsor
Iran University of Medical Sciences
Start
Jun 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of cefalexin in Facial wound, sponsored by Iran University of Medical Sciences. Started Jun 2026; status: recruiting.

02

Drugs

cefalexin
03

Conditions

Facial wound

Beyond the preview

Go deeper on IRCT20260513069382N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20260513069382N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call